Results 41 to 50 of about 112,020 (111)

Impact Of Vulvovaginal Atrophy Of Menopause In Spanish Women: Prevalence And Symptoms According To The EVES Study

Sexual Medicine, 2019
Introduction: The prevalence of menopausal women with confirmed vulvovaginal atrophy (VVA) oscillates between 67–98%. Aim: To assess the prevalence of postmenopausal women with VVA confirmed by gynecologic clinical assessment among all women attending ...
Santiago Palacios, MD, PhD, Silvia P. González, MD, PhD, Micaela Fernández-Abellán, MD, Montserrat Manubens, MD, PhD, Pascual García-Alfaro, MD, C.Argudo Prieto, L.Baquedano Mainar, J.Calleja Abu-Amshah, M.J.Cancelo Hidalgo, C. Castelo-Branco i Flores, P.Coronado Martin, M.Correa Rancel, M.Fernández Abellán, J.M.Fernández Moya, P.García Alfaro, M.González Fernández, S.González Rodríguez, E.Iglesias Bravo, P.Llaneza Coto, M.Manubens Grau, P.Marín Sánchez, N.Mendoza Ladrón de Guevara, B.Otero García-Ramos, S. Palacios, J.C.Presa Lorite, R.Sánchez Borrego, S.Sánchez Méndez, F.Vázquez Fernández   +27 more
doaj   +1 more source

Vaginal Laser Treatment for Genitourinary Syndrome of the Menopause: A Dose‐Determining Study in Breast Cancer Survivors

Lasers in Surgery and Medicine, EarlyView.
ABSTRACT Objectives Breast cancer survivors (BCSs) receiving endocrine therapy frequently develop genitourinary syndrome of menopause, characterized by vaginal dryness, pain, and urinary symptoms. Fractional CO2 vaginal laser therapy has been proposed as a non‐hormonal management option, but the optimal number of treatment sessions remains unclear.
Sine Jacobsen, Marianne Glavind‐Kristensen, Anders Bonde Jensen, Axel Forman, Vibe Munk Bertelsen, Pinar Bor   +5 more
wiley   +1 more source

Comparison of the Effect of Vitamins D and E with Conjugated Estrogen Vaginal Cream on Menopausal Vulvovaginal Symptoms: A Randomized Control Trials [PDF]

Studies in Multidisciplinary Medical Research
Menopausal vulvovaginal symptoms are common among postmenopausal women. Owing to the contraindications and limited availability of standard treatments, there is an increasing demand for alternative therapies.
Sayad Nazari, Tayyebeh Hashemi Arani, Fatemeh Sadat Asgarian, Seyed Gholam Abbas Mousavi, Zohreh Tabassi   +4 more
doaj   +1 more source

Carbon Dioxide Laser Vulvovaginal Rejuvenation: A Systematic Review

Cosmetics, 2021
Genitourinary syndrome of menopause (GSM) causes significant symptomatic aggravation that affects the quality of life (QoL). Vulvovaginal atrophy (VVA), the hallmark of GSM, is managed with topical non-hormonal therapy, including moisturizers and ...
Tassahil Messas, Achraf Messas, George Kroumpouzos   +2 more
doaj   +1 more source

The Role of Vaginal Oestrogen Therapy in Postmenopausal Women With Pelvic Organ Prolapse: Does It Have Any Impact on Perioperative Outcomes? A Systematic Review of Randomised Controlled Trials

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Background Pelvic organ prolapse (POP) affects up to 50% of postmenopausal women, negatively impacting sexual function and quality of life. While surgery remains the primary treatment, increasing attention has been given to perioperative vaginal oestrogen therapy and its potential impact on surgical outcomes.
Gilda Sicilia, Salvatore Giovanni Vitale, Maurizio Nicola D'Alterio, Stefania Saponara, Francesco Scicchitano, Anna Maria Fulghesu, Rossella E. Nappi, Stefano Angioni   +7 more
wiley   +1 more source

Modern Management of the Menopause: Are We Measuring What Matters?

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective Assess uptake of the Core Outcomes in Menopause (COMMA) core outcome sets (COS) and examine whether frontline treatments for vasomotor and genitourinary symptoms have been evaluated against these key outcomes. Design Methodological review. Setting Published literature and international clinical trial registries.
Joscelyn Gan, Michelle Steeper, Tim Hillard, Monica Christmas, Jan Shifren, Nick Panay, Martha Hickey, Sarah Lensen   +7 more
wiley   +1 more source

Post-menopausal vulvovaginal atrophy — an overview of the current treatment options [PDF]

, 2018
Sex hormone deficiency in post-menopausal women causes changes in the lower urinary tract. Vulvovaginal atrophy is a pathology resulting from those changes. VVA has a negative effect on the quality of life therefore prompting a search for new therapeutic
Siekierski, Bogumił Paweł; St Sophia Hospital in Warsaw, Żelazna 90 St., 01-004 Warsaw, Poland, Kajdy, Anna; St Sophia Hospital in Warsaw, Żelazna 90 St., 01-004 Warsaw, Poland, Szymański, Jacek Krzysztof; St Sophia Hospital in Warsaw, Żelazna 90 St., 01-004 Warsaw, Poland, Jakiel, Grzegorz; 1st Department of Obstetrics and Gynecology, Centre of Postgraduate Medical Education, Warsaw, Poland   +3 more
core   +1 more source

Comparison of the Effects of Vaginal Royal Jelly and Vaginal Estrogen on Quality of Life, Sexual and Urinary Function in Postmenopausal Women [PDF]

Journal of Clinical and Diagnostic Research, 2016
Introduction: Several causes can disturb the quality of life in postmenopausal women. Stress, urinary incontinence is one of the factors that can influence the quality of life of women, since they evade social activities and limit their behavior ...
Fatemeh Seyyedi, Mahmoud Rafieian-Kopaei, Sepideh Miraj   +2 more
doaj   +1 more source

Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions

Clinical Endocrinology, EarlyView.
ABSTRACT Objective To provide clinicians involved in managing menopause with a summary of current evidence surrounding menopause hormone therapy (MHT). Design The authors evaluate and synthesize existing pooled evidence relating to MHT's clinical indications, efficacy, and safety and explore the limitations of existing data. Patients The review focuses
Annice Mukherjee, Susan R. Davis
wiley   +1 more source

Menopausal hormone therapy and comprehensive postmenopausal care in gynecologic cancer survivors: A position paper from the FIGO Committee on Women at Menopausal Age

International Journal of Gynecology &Obstetrics, Volume 174, Issue 3, Page 1151-1171, September 2026.
Abstract Recent advances in cancer screening, diagnosis, and treatment have greatly improved survival rates among women with gynecologic cancers. More survivors now live long enough to experience treatment‐related menopause. Vasomotor symptoms, genitourinary syndrome of menopause, sexual dysfunction, sleep issues, and long‐term risks from estrogen ...
Agnaldo Lopes da Silva‐Filho, Suvarna Khadilkar, Hema Divakar, Chiara Benedetto, Andrea R. Genazzani, Diana Ramos, Elizabete Argale, Enrique Herrera, Martha Hickey   +8 more
wiley   +1 more source